Contact us
Back to top
Live:
Coronavirus Updates

New Clinical Trial Testing Remdesivir Plus Baricitinib as COVID-19 Treatment

A new clinical trial from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), will look at remdesivir plus baricitinib as a potential COVID-19 treatment.

Remdesivir is an intravenous antiviral drug that's been studied recently as a COVID-19 treatment on its own, and a recent analysis showed that remdesivir can help shorten recovery time compared to patients who got a placebo. Baricitinib (under the brand name Olumiant) is an anti-inflammatory drug that's taken orally and that's approved in the United States as a treatment for adults with moderate to severe rheumatoid arthritis.

Researchers are anticipating enrolling more than 1,000 participants in this clinical trial in the United States and internationally. Eligible patients who wish to enroll must have a confirmed SARS-CoV-2 infection and evidence of lung involvement, including the need for supplemental oxygen, abnormal chest X-rays or an illness requiring mechanical ventilation, according to the press release on the clinical trial. Those with only mild or no symptoms will not be included in this study.

This new clinical trial will randomly assign eligible participants to one of two treatments: participants will receive tablets of baricitinib and remdesivir in an IV or participants will receive placebo tablets and remdesivir in an IV.

Researchers will look at if recovery time is shorter in the combination treatment (baricitinib plus remdesivir) in comparison to remdesivir alone.

Read more about the clinical trial.

HealthDay Now: FDA Rejects Advisory Board to Approve Alzheimer's Drug

In our latest HealthDay Now interview, Mabel Jong spoke to Dr. G. Caleb Alexander, a professor at Johns Hopkins who served on the FDA advisory committee that nearly unanimously advised against approving Biogen's new Alzheimer's drug. Dr. Alexander shared his thoughts on the drug's highly uncertain efficacy and discussed whether the FDA's reputation has been permanently damaged by the controversial approval of the drug.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HD Live! Videos

HealthDay Now: Experts Weigh In On Alzheimer's Drug Controversy

HealthDay Now: Diabetes Care in 2021

HealthDay Now: Cancer Experts Share Highlights From Two Conferences

Two world-renowned medical groups — the European Hematology Association (EHA) and the International Conference on Malignant Lymphoma (ICML) — conducted virtual meetings this month to share advances in the care of blood-based cancers.

In our latest HealthDay Now, Dr. Joshua Richter, assistant professor of medicine at the Tisch Cancer Institute, gave insights on the EHA meeting. Then, Dr. Anastasios Stathis, an oncologist and a member of this year's ICML organizing committee, joined us to discuss ICML.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.


HealthDay Now: ASCO 2021 Highlights

In our latest HealthDay Now, Mabel Jong spoke with Dr. Lori Pierce, president of the American Society of Clinical Oncology and a cancer radiation specialist at the University of Michigan.

Dr. Pierce shared important takeaways from the recently concluded 2021 ASCO annual meeting and discussed why equity was the chosen theme this year.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: Why the COVID-19 Vaccine is Safe for Kids and How Vaccine Myths Impact Families

In our latest HealthDay Now, Dr. Hina Talib, a pediatrician and adolescent health specialist at the Children's Hospital at Montefiore, debunks myths and common concerns parents may have about giving their children Pfizer's COVID-19 vaccine, which was recently approved for use in children and teens ages 12 and up.

HealthDay Now's Mabel Jong also speaks with Alan Santee, a high school freshman from Massachusetts, about why he didn't hesitate to get vaccinated, and Ethan Lindenberger, a 20-year-old vaccine advocate from Ohio, about his experience having a mom who is anti-vaccine and how kids and parents can approach these conversations.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: The State of Mental Health and Post-COVID Stress Disorder

Watch our latest HealthDay Now to hear about the state of mental health and why many people fear returning to their social and work lives.

HealthDay's Mabel Jong spoke to Dr. Vivian Pender, president of the American Psychiatric Association, and Sherry Amatenstein, a social worker and therapist who has been dealing with these anxieties herself.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: The Rural Doctor Shortage and More From the 2021 ACP Annual Meeting

Watch our latest HealthDay Now for a preview of the American College of Physicians Annual Meeting 2021, covering topics like the alarming shortage of primary care physicians, bringing basic health delivery needs to rural residents, and why the ACP will focus on privacy concerns at its conference.

HealthDay Now's Mabel Jong speaks with Dr. Jacqueline Fincher, president of the American College of Physicians and an internist in a rural community in Georgia.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: The Latest on the Johnson & Johnson COVID-19 Vaccine Investigation

Watch our latest HealthDay Now as we cover the latest on the Johnson & Johnson COVID-19 vaccine investigation. An independent advisory panel to the CDC is waiting on additional information before making recommendations on the use of the Johnson & Johnson COVID-19 vaccine after reports about rare blood clots.

Mabel Jong from our liveblog team speaks with Lynn Bahta, a member of the CDC's Advisory Committee on Immunization Practices (ACIP) and a clinical expert for vaccines at the Minnesota Department of Health.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: American Association for Cancer Research Annual Meeting 2021 Recap

Watch our latest HealthDay Now as we recap the highlights of the American Association for Cancer Research (AACR) Annual Meeting 2021.

Mabel Jong from our liveblog team speaks with Dr. Antoni Ribas, former president of the American Association for Cancer Research and professor of medicine at UCLA, and Anna Plym, PhD, a postdoctoral research fellow at Brigham and Women's Hospital.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.

HealthDay Now: The Latest on Multisystem Inflammatory Syndrome in Children (MIS-C)

Watch our latest HealthDay Now as we dive into the latest details on multisystem inflammatory syndrome in children (MIS-C).

Mabel Jong from our liveblog team speaks with Dr. Mary Beth Son, Program Director of Boston Children's Hospital's Rheumatology Program, and Brian Padla, father of James Padla, who has MIS-C.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.